iressa
Pharmaranks rates Iressa 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Iressa (Gefitinib) is a kinase inhibitor used to treat Non-Small-Cell Lung Carcinoma.
Gefitinib · by Astrazeneca
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Gefitinib
- Drug class
- Kinase Inhibitor
- Form
- Tablet
- Strength
- Gefitinib 250MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- non-small-cell lung carcinoma
- Manufacturer
- Astrazeneca
- FDA application
- NDA021399
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Iressa ranks — best-rated kinase inhibitor for:
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Iressa treat?
- Iressa (Gefitinib) may be used to treat non-small-cell lung carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Iressa work?
- Iressa is a kinase inhibitor. Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.
- How is Iressa rated?
- pharmaranks gives Iressa a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Iressa?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Iressa. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Iressa?
- Iressa is marketed by Astrazeneca. You can see Astrazeneca's full profile, rating, and other products on pharmaranks.
- Is Iressa a brand-name or generic drug?
- Iressa is a brand-name product with the active ingredient Gefitinib.
- Is Iressa available over the counter?
- No. Iressa is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Iressa come in?
- Iressa is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Iressa?
- Iressa is classified as kinase inhibitor, per the FDA's Established Pharmacologic Class.
- Is Iressa FDA-registered?
- Iressa is on record with the U.S. FDA under application number NDA021399. You can verify this on its official FDA label.
- Has Iressa been recalled by the FDA?
- Iressa has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Iressa safe?
- There's no single safe-or-not verdict. pharmaranks gives Iressa a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
ofev
Nintedanib Esylate
sprycel
Dasatinib
afinitor
Everolimus
calquence
Acalabrutinib
cotellic
Cobimetinib Fumarate
danziten
Nilotinib Tartrate
Compare Iressa head-to-head
More kinase inhibitor drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
iressa
70/100